RxSight, Inc. logo

RxSight, Inc.

NASDAQ:RXST

Overview | Financials
Company Name RxSight, Inc.
Symbol RXST
Currency USD
Price 33.66
Market Cap 1,356,649,470
Dividend Yield 0%
52-week-range 33.03 - 66.54
Industry Medical Devices
Sector Healthcare
CEO Dr. Ronald M. Kurtz M.D.
Website https://www.rxsight.com

An error occurred while fetching data.

About RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Related Stocks

Incannex Healthcare Limited logo

Incannex Healthcare Limited

IXHL

0.84 USD

Science 37 Holdings, Inc. logo

Science 37 Holdings, Inc.

SNCE

5.75 USD

Nyxoah S.A. logo

Nyxoah S.A.

NYXH

8.01 USD

Repare Therapeutics Inc. logo

Repare Therapeutics Inc.

RPTX

1.32 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

19.03 USD

OrganiGram Holdings Inc. logo

OrganiGram Holdings Inc.

OGI

1.56 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

6.15 USD

Sight Sciences, Inc. logo

Sight Sciences, Inc.

SGHT

3.57 USD

Protagonist Therapeutics, Inc. logo

Protagonist Therapeutics, Inc.

PTGX

41.49 USD

Financials

Numbers are in millions USD

Numbers are in millions USD